FirsthandHealth
medRxiv PreprintsInternational17 November 2026

Accurate Prediction of Hepatic Disease Severity in MASLD Using a Learned Phenotype

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background & Aims: Most prognostic models for metabolic dysfunction-associated steatotic liver disease (MASLD) target prespecified hepatic endpoints, potentially limiting attainable accuracy. We developed and externally validated a model that learns the future hepatic phenotype most reliably predictable from baseline clinical characteristics. Methods: We analyzed 332 HALO-MASLD participants (456 follow-up observations). Sparse Canonical Outcome REgression (SCORE) learned a weighted phenotype from eight hepatic measures, coupled with broken adaptive ridge regression using 99 baseline predictor
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.